MBNL3 Antikörper (Middle Region)
Kurzübersicht für MBNL3 Antikörper (Middle Region) (ABIN953338)
Target
Alle MBNL3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 250-280, Middle Region
-
Spezifität
- This antibody recognizes Human MBNL3 (Center).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- conjugated synthetic peptide between 250-280 amino acids from the Central region of human MBNL3
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MBNL3 (Muscleblind-Like Splicing Regulator 3 (MBNL3))
-
Andere Bezeichnung
- MBNL3
-
Hintergrund
- This gene encodes a member of the muscleblind-like family of proteins. The encoded protein may function in regulation of alternative splicing and may play a role in the pathophysiology of myotonic dystrophy. Alternatively spliced transcript variants have been described.Synonyms: CHCR, Cys3His CCG1-required protein, HCHCR, MBLX39, MBXL, Muscleblind-like X-linked protein, Muscleblind-like protein 3
-
Molekulargewicht
- 38532 Da
-
Gen-ID
- 55796
-
NCBI Accession
- NP_001164172
-
Pathways
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Target
-